Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer
Status:
Terminated
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
This randomized pilot clinical trial studies rosuvastatin in treating women with
cardiovascular complications who are undergoing chemotherapy for breast cancer. Rosuvastatin
may prevent or lessen cardiovascular complications in patients undergoing chemotherapy for
breast cancer
Phase:
Phase 1
Details
Lead Sponsor:
Comprehensive Cancer Center of Wake Forest University Wake Forest University Health Sciences